BearDownAZ's Recent Posts
Title Rating Company Posted on
Re: AGM & PP 9 Resverlogix Corp. Nov 23, 2020 08:50PM
Zenith Files Notice of Annual and Special Meeting of Shareholders 1 Zenith Epigenetics Nov 21, 2020 08:48AM
Resverlogix Files Notice of Annual and Special Meeting of Shareholders 1 Resverlogix Corp. Nov 21, 2020 08:46AM
Re: Who removed my post? 11 Resverlogix Corp. Nov 17, 2020 03:39PM
Re: Vaccine 2 Resverlogix Corp. Nov 17, 2020 09:46AM
Re: BETonRENAL 6 Resverlogix Corp. Nov 17, 2020 09:43AM
Re: Vaccine 10 Resverlogix Corp. Nov 16, 2020 10:31AM
Re: AHA Posters are published 5 Resverlogix Corp. Nov 16, 2020 10:26AM
Re: Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics 2 Resverlogix Corp. Nov 12, 2020 09:48AM
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics 4 Resverlogix Corp. Nov 12, 2020 09:46AM
Re: Why is agora deleting posts?? Was that last one to honest??? Zenith Epigenetics Nov 11, 2020 04:49PM
Re: AHA Abstracts will be posted Monday 11/9 at 4AM CST 7 Resverlogix Corp. Nov 09, 2020 10:55AM
Re: Hmmmm Covid News... 2 Resverlogix Corp. Nov 09, 2020 10:45AM
AHA Abstracts will be posted Monday 11/9 at 4AM CST 6 Resverlogix Corp. Nov 08, 2020 12:31PM
Re: Election Day 5 Resverlogix Corp. Nov 05, 2020 10:09PM
Re: Bioasis Announces Sale of Royalty Interest in LSD Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation 2 BIOASIS TECHNOLOGIES INC Nov 04, 2020 05:33PM
Bioasis Announces Sale of Royalty Interest in LSD Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation 2 BIOASIS TECHNOLOGIES INC Nov 04, 2020 05:32PM
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers 9 Resverlogix Corp. Nov 02, 2020 07:56AM
Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers 6 Resverlogix Corp. Nov 02, 2020 07:46AM
Zenith Confirms Interim Filings on SEDAR 2 Zenith Epigenetics Oct 28, 2020 10:34AM